Bismacine

Below is a FDA news release regarding the use of bismacine, also known as chromacine, an “alternative health” product that has been used to treat Lyme disease. The bismacine (chromacine) contains high amounts of bismuth and is injected into the patient. This can cause bismuth poisoning, which can lead to death or serious injury, including cardio-vascular collapse and kidney failure. Cardio-vascular collapse is “the sudden loss of consciousness due to failure of the heart to pump enough blood to the brain (2)." It is a life-threatening event. PritzkerOlsen, P.A. , a premier product liability law firm, is reprinting the FDA news release regarding bismacine (chromacine) and bismuth poisoning as a public service.

Lawyer Fred Pritzker has over 30 years of product liability lawsuit experience. He is a member of the American Board of Trial Advocates and the Million Dollar Advocates Forum. He has been selected by his peers for inclusion in the Current edition of The Best Lawyers in America. To contact PritzkerOlsen, P.A., call toll-free at 1-888-377-8900 or fill out our online consultation form.

FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine
July 21, 2006 – The U.S. Food & Drug Administration (FDA) is warning consumers and health care providers not to use a product called "bismacine," also known as chromacine. The FDA is investigating one report of a death and several reports of injury related to the administration of bismacine.

Bismacine is an injectable product that has been used to treat Lyme disease. But bismacine is not approved for anything, including Lyme disease.

Bismacine is not a pharmaceutical and is mixed individually by druggists. It is prescribed or administered by doctors of "alternative health" or by people claiming to be medical doctors.

This product contains high amounts of bismuth, a heavy metal that is used in some medications taken by mouth to treat Helicobacter pylori (a bacteria that can cause stomach ulcers), but that is not approved in any form for use by injection.

On April 20, 2006, one person died as a result of treatment with bismacine, and on March 29, 2005, another person was hospitalized after receiving a bismacine treatment. Other individuals who have used or been administered this product have also suffered serious adverse events. Possible effects of bismuth poisoning include cardio-vascular collapse and kidney failure.

FDA is advising consumers and health care providers not to use bismacine. Individuals who believe they have suffered adverse events from receiving bismacine may wish to seek medical attention.

FDA is evaluating the product suppliers and will take additional action as appropriate.

Report adverse reactions experienced with the use of this product to the FDAs MedWatch Adverse Event Reporting program online at www.fda.gov/MedWatch/report.htm, by phone (1-800-FDA-1088), or by returning the postage-paid FDA form 3500, which may be downloaded from www.fda.gov/MedWatch/getforms.htm, by mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 or fax (1-800-FDA-0178).

Sources:

FDA news release regarding bismacine (chromacine), July 21, 2006, http://www.fda.gov/bbs/topics/NEWS/2006/
Cardiovascular Collapse: Mechanisms of Individual Variability in Susceptibility to Syncope, Information on Levine Awards, http://www.ieemphd.com/current_awardsben.htm

Free Case Consultation

We are Not Paid Unless You Win

Our attorneys work on a continguency fee basis, meaning you do not have to pay our law firm for representing you unless we win you money.

Firm News

AV Preeminent Rating by Martindale-Hubbell

Attorneys Fred Pritzker and Eric Hageman have been given the highest rating by Martindale-Hubbell for attorney, AV Preeminent. An AV® certification mark is a significant rating accomplishment - a testament to the fact that a lawyer's peers rank him or her at the highest level of professional excellence.

Adjunct Teaching Position At U of M Law School

Attorney Brendan Flaherty has accepted an adjunct teaching position at the University of Minnesota Law School. For the 2011 spring semester, Flaherty will teach a course entitled "Practice and Professionalism," which will introduce students to foundational lawyering skills and professional responsibility issues.

Attorney Elliot Olsen Speaks at Conference

Attorney Elliot Olsen recently spoke at the Seventh Annual LifeScience Alley Conference in Minneapolis on Preemption and the Future of Medical Device Litigation. He appeared with Randall Pattee of Lindquist and Vennum and Jean Lance, VP of corporate legal and general counsel for Boston Scientific.

Named Super Lawyer

In recognition of their achievements, Attorneys Fred Pritzker, Elliot Olsen and Eric Hageman were named "Super Lawyers" by Law & Politics magazine. According to Super Lawyers, "The objective is to create a credible, comprehensive and diverse listing of outstanding attorneys that can be used as a resource to assist attorneys and consumers in the search for legal counsel."

Brendan Flaherty Named a Rising Star

In recognition of his achievements, Attorney Brendan Flaherty was named a 2010 Rising Star by Minnesota Law & Politics. Only 2.5 percent of the state’s lawyers are included on the list, which highlights Minnesota’s best up-and-coming legal talent.

Fred Pritzker Listed in The Best Lawyers in America

Fred Pritzker has been notified that he will again be listed in The Best Lawyers in America for his work in personal injury litigation.

This is attorney advertising. Past results do not guarantee a similar outcome. The result of each case is determined by the specific facts and the applicable law.